The Orphan Nuclear Receptor Rev-Erbα Is a Peroxisome Proliferator-activated Receptor (PPAR) γ Target Gene and Promotes PPARγ-induced Adipocyte Differentiation*

  1. Bart Staels,**
  1. UR545 INSERM, Département d'Athérosclérose, 1, rue Calmette, Institut Pasteur de Lille, 59019 Lille, France, and Faculté de Pharmacie, Université de Lille II, 59006 Lille, France, the Institut de Biologie de Lille, 1 rue Calmette, 59021 Lille, France, and the Department of Biochemistry and Molecular Biology, University of Southern Odense 5230, Denmark
  1. ** To whom correspondence should be addressed: UR545 INSERM, Département d'Athérosclérose, Institut Pasteur, 1 rue Calmette, 59019 Lille, France. Tel.: 33-3-20-87-73-88; Fax: 33-3-20-87-71-98; E-mail: Bart.Staels{at}pasteur-lille.fr.

Abstract

Rev-Erbα (NR1D1) is an orphan nuclear receptor encoded on the opposite strand of the thyroid receptor α gene. Rev-Erbα mRNA is induced during adipocyte differentiation of 3T3-L1 cells, and its expression is abundant in rat adipose tissue. Peroxisome proliferator-activated receptor γ (PPARγ) (NR1C3) is a nuclear receptor controlling adipocyte differentiation and insulin sensitivity. Here we show that Rev-Erbα expression is induced by PPARγ activation with rosiglitazone in rat epididymal and perirenal adipose tissues in vivo as well as in 3T3-L1 adipocytes in vitro. Furthermore, activated PPARγ induces Rev-Erbα promoter activity by binding to the direct repeat (DR)-2 response element Rev-DR2. Mutations of the 5′ or 3′ half-sites of the response element totally abrogated PPARγ binding and transcriptional activation, identifying this site as a novel type of functional PPARγ response element. Finally, ectopic expression of Rev-Erbα in 3T3-L1 preadipocytes potentiated adipocyte differentiation induced by the PPARγ ligand rosiglitazone. These results identify Rev-Erbα as a target gene of PPARγ in adipose tissue and demonstrate a role for this nuclear receptor as a promoter of adipocyte differentiation.

  • Received May 5, 2003.
Table of Contents

This Article

  1. The Journal of Biological Chemistry 278, 37672-37680.
  1. All Versions of this Article:
    1. M304664200v1
    2. 278/39/37672 (most recent)

Article Usage Stats

Submit your work to JBC.

You'll be in good company.